The Chikungunya Virus nsP3 Macro Domain Inhibits Activation of the NF-κB Pathway

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• The chikungunya virus (CHIKV) non-structural protein 3 (nsP3) has a poorly defined role in the viral lifecycle.
• nsP3 possesses a macro domain with RNA and ADP-ribose binding capabilities and ADP-ribosyl hydrolase activity.
• ADP-ribosylation influences signaling pathways, including NF-κB activation.

Purpose of the Study:

• To investigate the role of the CHIKV nsP3 macro domain in NF-κB signaling.
• To determine if nsP3 can modulate NF-κB activation during CHIKV infection or expression.
• To assess the impact of nsP3's macro domain activity on CHIKV replication and infectivity.

Main Methods:

• Assessing NF-κB activation in CHIKV-infected cells and cells expressing nsP3.
• Utilizing TNFα to induce and test inhibition of NF-κB activation.
• Employing a D10A mutant of nsP3's macro domain to evaluate the importance of its enzymatic activity.
• Measuring CHIKV infectivity with wild-type and mutant nsP3 expression.

Main Results:

• CHIKV infection did not induce or block NF-κB activation, though TNFα treatment modestly reduced CHIKV titer.
• Ectopic expression of nsP3 inhibited both basal and TNFα-induced NF-κB activation.
• Inhibition of NF-κB by nsP3 required the macro domain's ADP-ribose binding and hydrolase activity, as shown by the D10A mutant.
• The D10A macro domain mutation significantly reduced CHIKV infectivity.

Conclusions:

• The nsP3 macro domain plays a critical role in CHIKV replication by inhibiting NF-κB signaling.
• nsP3's ability to modulate NF-κB activation is essential for efficient CHIKV lifecycle progression.
• Targeting the nsP3-NF-κB interaction could be a strategy for CHIKV antiviral therapies.